Mitophagy-mediated inflammation and oxidative stress contribute to muscle wasting in cancer cachexia.
Level 5 - mechanism / opinion, no new human data
Preclinical animal experiment combined with descriptive human observational data.
PubMed 37534096 · doi:10.3164/jcbn.23-1
What was done
Evaluated clinical data (CT scans and laboratory results) from patients with cancer cachexia alongside a mouse model of cancer cachexia with mitophagy inhibition. Measured skeletal muscle mass and function, mitochondrial structure and function (including ATP production), inflammatory factors, and reactive oxygen species (ROS) levels.
What was found
The abstract reports no numerical values, effect sizes, or statistical metrics. It describes enhanced mitophagy and increased inflammatory factors in cancer cachexia patients, as well as disrupted muscle fiber and mitochondrial architecture, elevated inflammatory factors and ROS, and reduced ATP production in cachectic mice.
Why it matters
Identifies mitophagy, inflammation, and oxidative stress as linked mechanisms contributing to mitochondrial disruption and muscle wasting in cancer cachexia.
Limits
No quantitative data, sample sizes, or statistical comparisons are provided in the abstract. Evidence relies heavily on an animal model, and human clinical observations are purely correlational.
Cited by
- supports Cellular autophagy is elevated in certain cancers and muscle-wasting diseases.